President Trump nominated White House domestic policy aide Dr. Heidi Overton, a physician, on August 19, 2026, to serve as FDA commissioner following Marty Makary’s departure in May. The Senate must confirm the nomination through the standard process of committee review and floor vote. Senate Health Committee Chairman Bill Cassidy immediately raised concerns, citing Overton’s involvement in a recent executive order on childhood vaccines. Traders are assessing confirmation prospects based on Republican Senate support, the committee’s hearing timeline, and any further signals from key senators or the White House on administration health priorities. No vote has occurred, leaving the outcome open to procedural developments in the coming weeks.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · Обновлено30 сентября
47%
31 октября
29%
30 ноября
53%
31 декабря
74%
$1,712 Объем
30 сентября
47%
31 октября
29%
30 ноября
53%
31 декабря
74%
If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”.
The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution.
The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.
Открытие рынка: Aug 20, 2026, 5:43 PM ET
Resolver
0x65070BE91...If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”.
The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution.
The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.
Resolver
0x65070BE91...President Trump nominated White House domestic policy aide Dr. Heidi Overton, a physician, on August 19, 2026, to serve as FDA commissioner following Marty Makary’s departure in May. The Senate must confirm the nomination through the standard process of committee review and floor vote. Senate Health Committee Chairman Bill Cassidy immediately raised concerns, citing Overton’s involvement in a recent executive order on childhood vaccines. Traders are assessing confirmation prospects based on Republican Senate support, the committee’s hearing timeline, and any further signals from key senators or the White House on administration health priorities. No vote has occurred, leaving the outcome open to procedural developments in the coming weeks.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · Обновлено



Не доверяй внешним ссылкам.
Не доверяй внешним ссылкам.
Часто задаваемые вопросы